Company Overview and News

 
Havells clocks Q4 profit rises to Rs226 crore

2018-05-11 livemint
New Delhi: Havells India on Friday reported a standalone net profit of Rs225.76 crore and total income of Rs2,560.64 crore for the quarter ended 31 March, 2018.

 
After acquisition by Havells India, Lloyd eyes ₹3,000-crore turnover

2017-10-09 thehindubusinessline
After acquiring the Lloyd brand of consumer durables early this year, Havells India is targeting sales of ₹3,000 crore from the white goods category.

 
Company news

2017-05-24 thehindubusinessline
India Cements has fixed June 9 as the record date to determine the shareholders of Trinetra Cement and Trishul Concrete Products who are eligible to receive equity shares of the company under a scheme of arrangement. The company has received approval from the National Company Law Tribunal, Division Bench, Chennai. Trinetra Cement (listed) and Trishul Concrete (unlisted) are subsidiaries of India Cements, which are to be merged with itself.

 
Reliance Retail-Heritage Foods deal, 2 others get CCI nod

2017-04-10 business-standard
The Competition Commission has approved the proposed acquisition of Reliance Retail's dairy business by Heritage Foods apart from two other deals. Havells' purchase of Lloyd's consumer durables and the deal involving DHFL Pramerica Life Insurance Company have been cleared, the watchdog said.

 
Fedders Lloyd Corporation intimates of listing of 32 lakh shares on exchanges

2017-03-18 indiainfoline
Disclaimer: The contents herein is specifically prepared by ‘Dalal Street Investment Journal’, and is for your information & personal consumption only. India Infoline Limited or Dalal Street Investment Journal do not guarantee the accuracy, correctness, completeness or reliability of information contained herein and shall not be held responsible.

 
Lloyd seeks shareholders' nod to sell consumer biz to Havells

2017-02-22 moneycontrol
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:

 
Analyst take: Havells-Lloyd deal 'win-win' for both

2017-02-20 moneycontrol
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:

 
Havells to buy Lloyds consumer durables biz for Rs 1600 cr

2017-02-19 moneycontrol
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:

 
Havells to buy Lloyd’s consumer durables biz

2017-02-19 thehindubusinessline
The deal, with an enterprise value of ₹1,600 crore, will help the firm enter white goods segment

 
Fedders Lloyd Corporation allots 11.40 lakh equity shares

2017-01-13 indiainfoline
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

 
Fedders Lloyd Corporation allots equity shares

2016-12-30 indiainfoline
Subsequent to the above allotment, the paid up share capital of the Company has increase to Rs 32.82 crore comprising of 3,28,29,700 equity shares of Rs 10 each.

 
New CEO for WABAG India cluster

2016-12-09 thehindubusinessline
VA Tech Wabag has appointed Pankaj Sachdeva as Chief Executive Officer (CEO) for WABAG India Cluster from November 28, 2016. He will be based in Chennai office and handle the management and supervision of the WABAG India Cluster of the integrated water and waste water management and recycling multinational, said a statement from the company.

 
Wabag India cluster appoints Pankaj Sachdeva as new CEO

2016-12-03 business-standard
Pankaj Sachdeva has been appointed as the new Chief Executive Officer (CEO) of Wabag India Cluster. Prior to joining Wabag, Sachdeva was Executive President with Fedders Lloyd Corporation. Previous to that, he was Joint Group President and Group Director at Skipper SEIL International, JLT, Dubai.

 
Fedders Lloyd Corp gains 4% on 2 orders worth Rs 390 cr

2016-11-15 moneycontrol
The company has bagged orders worth Rs 296 crore from Chhattisgarh State Power Distribution Company under the Deen Dayal Upadhyay Gramin Jyoti Yojna (DDUGJY).

 
Stocks in news: Tata Motors, Axis, BoB, Hindalco, Ujjivan, Dish

2016-11-15 moneycontrol
Tata Motors | Tata Steel | Axis Bank | Bank of Baroda | Hindalco Industries | Patel Engineering | LT Foods | SREI Infra | Ujjivan | Dish TV | Future Retail | Kotak Mahindra Bank | Fedders Lloyd | HSIL | Indian Hume Pipe | Fiem Industries and Suzlon are stocks, which are in the news today.

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...